Small molecule synthesis
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH17C0264
- Awardee
-
Epigen Biosciences Inc. UEI L1EDVCGK2327
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $860,773
Award facts
- Opportunity
-
- W81XWH17R0052 Solicitation number
- Small molecule synthesis Award Notice · Posted Jul 6, 2017
- Contract value 79% obligated
- $1,094,682.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Frederick, MD 21701, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$69,824 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | -$14,849 | |
| Exercise an Option | $25,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $94,881 | |
| Exercise an Option | $88,697 | |
| Supplemental Agreement for work within scope | -$88,697 | |
| Funding Only Action | $98,400 | |
| Funding Only Action | $35,702 | |
| Funding Only Action | $22,447 | |
| Funding Only Action | $14,853 | |
| Change Order | $14,853 | |
| Change Order | $0 | |
| Funding Only Action | -$133,000 | |
| Funding Only Action | $80,000 | |
| Exercise an Option | $178,231 | |
| Other Administrative Action | $173,040 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $173,040 | |
| Other Administrative Action | $19,604 | |
| Funding Only Action | $104,396 | |
| Original award | $44,000 |
Show all 24
About this award
This is a $1,094,682.00 Firm Fixed Price contract awarded by the U.S. Army Medical Command (MEDCOM) to Epigen Biosciences Inc., a small business based in San Diego, California. The contract is for the research and development of small molecule compounds, with a focus on potential therapeutic applications in areas such as stroke, liver diseases, neurodegenerative disorders, and neuropathic conditions. Epigen Biosciences has received prior grant funding from various National Institutes of Health (NIH) agencies for its work on novel compound development targeting specific receptor systems. This contract appears to be part of the agency's efforts to support small business innovation in the pharmaceutical and biotechnology fields.
Quick answers
Who was awarded contract W81XWH17C0264?
W81XWH17C0264 was awarded to Epigen Biosciences Inc. by Medical Command (Department of the Army) on September 25, 2017.
How much is contract W81XWH17C0264 worth?
The government has obligated $860,773 on W81XWH17C0264. Its current value, with exercised options, is $1,094,682.
Was contract W81XWH17C0264 competed?
The extent of competition for W81XWH17C0264 was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award